Beyond Air, Inc. (NASDAQ:XAIR – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 1,750,000 shares,  a growth of 24.1% from the March 15th total of 1,410,000 shares. Based on an average daily trading volume, of 334,200 shares, the days-to-cover ratio is presently 5.2 days.

In related news, Director Robert Carey acquired 10,000 shares of the firm’s stock in a transaction on Thursday, March 30th. The shares were purchased at an average price of $6.45 per share, with a total value of $64,500.00. Following the acquisition, the director now directly owns 886,496 shares in the company, valued at $5,717,899.20. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, Director Robert Carey acquired 10,000 shares of the company’s stock in a transaction that occurred on Thursday, March 30th. The stock was purchased at an average price of $6.45 per share, for a total transaction of $64,500.00. Following the transaction, the director now directly owns 886,496 shares of the company’s stock, valued at approximately $5,717,899.20. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Steven A. Lisi bought 45,000 shares of the stock in a transaction dated Tuesday, March 7th. The stock was purchased at an average cost of $5.98 per share, with a total value of $269,100.00. Following the completion of the purchase, the chief executive officer now directly owns 1,442,849 shares in the company, valued at approximately $8,628,237.02. The disclosure for this purchase can be found here. Insiders acquired 96,588 shares of company stock valued at $591,087 over the last ninety days. 15.58% of the stock is owned by insiders.

A number of large investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in  Beyond Air by 6.8% during the 1st quarter. BlackRock Inc. now owns 264,900 shares of the company’s stock worth $1,769,000 after acquiring an additional 16,968 shares during the last quarter.  Vanguard Group Inc. raised its holdings in  Beyond Air by 1.6% in the first quarter. Vanguard Group Inc. now owns 923,049 shares of the company’s stock worth $6,166,000 after purchasing an additional 14,939 shares during the period.  Charles Schwab Investment Management Inc. bought a new position in shares of  Beyond Air during the first quarter worth $94,000.  Northern Trust Corp grew its holdings in shares of  Beyond Air by 11.0% in the 1st quarter. Northern Trust Corp now owns 80,720 shares of the company’s stock valued at $539,000 after buying an additional 8,007 shares during the period.  Finally, Renaissance Technologies LLC increased its position in shares of  Beyond Air by 123.0% in the 1st quarter. Renaissance Technologies LLC now owns 152,300 shares of the company’s stock valued at $1,017,000 after buying an additional 83,998 shares in the last quarter. Institutional investors and hedge funds own  19.05% of the company’s stock.

Shares of NASDAQ XAIR opened at $6.16 on Wednesday. Beyond Air has a 1 year low of $4.78 and a 1 year high of $11.76. The firm’s 50-day moving average is $6.33 and its 200-day moving average is $6.40. The firm has a market capitalization of $185.35 million, a PE ratio of -3.19 and a beta of -0.31.

Beyond Air (NASDAQ:XAIR – Get Rating) last announced its quarterly earnings data on Thursday, February 9th. The company reported ($0.43) earnings per share for the quarter, missing the consensus estimate of ($0.42) by ($0.01).  As a group, equities research analysts anticipate that  Beyond Air will post -1.63 earnings per share for the current fiscal year.

Beyond Air, Inc is a clinical-stage medical device and biopharmaceutical company. It engages in developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases.

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.